SCHEDULE 13G/A: BlackRock Discloses 8.3% Stake in Mind Medicine Inc. as of Year-End 2024
Ownership Disclosure
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.3% of Mind Medicine (MindMed) Inc.'s common stock as of December 31, 2024.
Summary
- BlackRock, Inc. has filed an Amendment No. 1 to Schedule 13G, disclosing its beneficial ownership in Mind Medicine (MindMed) Inc.
- As of December 31, 2024, BlackRock beneficially owns 6,070,053 shares of Mind Medicine (MindMed) Inc. common stock.
- This aggregate amount represents 8.3% of the total outstanding common stock of Mind Medicine (MindMed) Inc.
- BlackRock holds sole voting power over 5,992,299 shares and sole dispositive power over 6,070,053 shares.
- The filing indicates that BlackRock acquired and holds these securities in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: The filing indicates a significant beneficial ownership by BlackRock, a major institutional investor, which can be seen as a positive signal of institutional confidence and liquidity for Mind Medicine (MindMed) Inc.
Positives
- BlackRock, a major institutional investor, maintaining a significant stake (8.3%) in Mind Medicine (MindMed) Inc. can be interpreted as a vote of confidence in the company's long-term prospects.
- The filing confirms BlackRock's continued interest and investment in the company.
Future Outlook
Not applicable. This filing is a historical disclosure of ownership as of a specific date, not a forward-looking statement from the issuer.
Industry Context
BlackRock, Inc. is one of the world's largest asset managers, and its filings of Schedule 13G indicate significant passive investment stakes in publicly traded companies. Such disclosures are routine for institutional investors holding more than 5% of a company's outstanding shares, reflecting their portfolio management activities rather than active corporate engagement or strategic intent to influence control.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, which can influence market perception and liquidity.
- Investors: Offers insight into institutional investment trends in Mind Medicine (MindMed) Inc.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | Date of event which requires filing of this statement, reflecting BlackRock's beneficial ownership position. |
| 2025-01-21 | Date of execution for the Power of Attorney document. |
| 2025-02-05 | Date of filing (signature date) for the Schedule 13G Amendment No. 1. |
Keywords
Mind Medicine (MindMed) Inc., BlackRock Inc., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, MMED, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.